Company profile: Peptilogics
1.1 - Company Overview
Company description
- Provider of clinical-stage therapeutics enabled by a computational deep learning platform for peptide drug discovery. Offerings include PLG0206, an investigational antibiotic peptide candidate for treating periprosthetic joint infection in clinical trial, an AI platform to predict peptide design across targets, and an expanded access policy for patients not qualifying for trials.
Products and services
- AI Platform: A deep learning-based computational platform that utilizes AI to predict peptide design across various targets for peptide drug discovery
- PLG0206: A clinical-stage antibiotic peptide candidate for treating periprosthetic joint infection, currently in clinical trial for infections associated with joint prostheses
- Expanded Access Policy: A policy-governed program outlining access to investigational drugs for patients not qualifying for clinical trials, under specific conditions
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Peptilogics
Rational Vaccines
HQ: United States
Website
- Description: Provider of pre-clinical live-attenuated herpes simplex virus vaccines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rational Vaccines company profile →
Meretek Diagnostics
HQ: United States
Website
- Description: Provider of non-invasive, non-radioactive breath tests and instruments for diagnostic applications, offering BreathTek UBT and BreathTek-UBiT collection kits for qualitative detection of urease associated with Helicobacter pylori in the human stomach, supporting initial diagnosis and post-treatment monitoring of Helicobacter pylori infection.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Meretek Diagnostics company profile →
Zavante
HQ: United States
Website
- Description: Provider of clinical-stage biopharmaceutical development of novel therapies to improve the outcomes of hospitalized patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Zavante company profile →
Nucleonics
HQ: United States
Website
- Description: Provider of RNA interference-based therapeutics as a biotechnology company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nucleonics company profile →
Abac Therapeutics
HQ: Spain
Website
- Description: Provider of precision antimicrobial drug discovery and development, creating first-in-class, pathogen-specific antibiotics for MDR Gram-negative infections. Offers the PasNas scalable, multiplexed platform to identify high-quality leads across compounds and bacterial species, and advances agents with suitable pharmacokinetics/toxicology, leveraging public-private collaborations to combat antimicrobial resistance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Abac Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Peptilogics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Peptilogics
2.2 - Growth funds investing in similar companies to Peptilogics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Peptilogics
4.2 - Public trading comparable groups for Peptilogics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →